All articles by Akosua Mireku

Akosua Mireku is a healthcare reporter for Pharmaceutical Technology. Akosua has a Bsc in medical physiology from the University of Manchester. She is particularly interested in topics in neuroscience, rare diseases, and global health equality

Akosua Mireku


FDA drug dosage optimisation guidelines signal clinical trial reform

The FDA chooses drug optimisation as the preferred blueprint for cancer trials, departing from the maximum tolerated dose model.

FDA suggests ways to curb constraints with rare disease gene therapy trials

At a recent town hall, FDA experts indicated how sponsors can navigate smaller rare disease patient populations for gene therapy trials.